Evidence map›Paper›PMID 39023648›Full record

ReviewEJNMMI physics2024

A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?

Laure Vergnaud, Yuni K Dewaraja, Anne-Laure Giraudet, Jean-Noël Badel, David Sarrut

Abstract readReview
In one paragraph

Review in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  2. Article
  3. Review
  4. Dosimetry inJournal of clinical medicine · 2026
    Review
  5. Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  6. Review
  7. Review
  8. Continuous βClinical and translational radiation oncology · 2025
    Article
  9. EJNMMI physics · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. 360° CZT-SPECT/CT cameras:EJNMMI physics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laure VergnaudCREATIS; CNRS UMR 5220; INSERM U 1044, Université de Lyon; INSA-Lyon; Université Lyon 1, Lyon, France. Laure.Vergnaud@creatis.insa-lyon.fr.ORCID http://orcid.org/0000-0003-3813-6467
Yuni K DewarajaDepartment of Radiology, University of Michigan, Ann Arbor, USA.
Anne-Laure GiraudetCentre de lutte contre le cancer Léon Bérard, Lyon, France.
Jean-Noël BadelCREATIS; CNRS UMR 5220; INSERM U 1044, Université de Lyon; INSA-Lyon; Université Lyon 1, Lyon, France.
David SarrutCREATIS; CNRS UMR 5220; INSERM U 1044, Université de Lyon; INSA-Lyon; Université Lyon 1, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DosimetryReviewSingle time-point

Identifiers

PMID39023648
PMCPMC11554969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.